A detailed history of Ubs Group Ag transactions in Kamada LTD stock. As of the latest transaction made, Ubs Group Ag holds 276 shares of KMDA stock, worth $1,518. This represents 0.0% of its overall portfolio holdings.

Number of Shares
276
Previous 19,488 98.58%
Holding current value
$1,518
Previous $109,000 99.08%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$4.78 - $5.75 $91,833 - $110,469
-19,212 Reduced 98.58%
276 $1,000
Q1 2024

May 13, 2024

SELL
$5.58 - $6.42 $312,067 - $359,044
-55,926 Reduced 74.16%
19,488 $109,000
Q4 2023

Feb 09, 2024

BUY
$4.14 - $6.22 $302,534 - $454,532
73,076 Added 3125.58%
75,414 $461,000
Q3 2023

Nov 09, 2023

BUY
$4.86 - $5.83 $11,362 - $13,630
2,338 New
2,338 $12,000
Q1 2023

May 12, 2023

BUY
$4.12 - $5.25 $194,698 - $248,099
47,257 Added 8984.22%
47,783 $221,000
Q4 2022

Feb 08, 2023

SELL
$3.79 - $4.84 $9,183 - $11,727
-2,423 Reduced 82.16%
526 $2,000
Q3 2022

Nov 10, 2022

BUY
$4.42 - $5.43 $2,249 - $2,763
509 Added 20.86%
2,949 $13,000
Q2 2022

Aug 10, 2022

BUY
$4.22 - $5.85 $7,958 - $11,033
1,886 Added 340.43%
2,440 $11,000
Q1 2022

May 16, 2022

SELL
$5.43 - $6.81 $14,807 - $18,570
-2,727 Reduced 83.11%
554 $3,000
Q4 2021

Feb 14, 2022

BUY
$5.21 - $6.82 $17,094 - $22,376
3,281 New
3,281 $22,000
Q3 2021

Nov 15, 2021

SELL
$5.25 - $5.87 $73,893 - $82,620
-14,075 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$5.67 - $6.33 $70,529 - $78,738
12,439 Added 760.33%
14,075 $82,000
Q1 2021

May 12, 2021

SELL
$6.02 - $8.06 $317,374 - $424,923
-52,720 Reduced 96.99%
1,636 $10,000
Q4 2020

Feb 11, 2021

SELL
$6.3 - $8.46 $249,303 - $334,779
-39,572 Reduced 42.13%
54,356 $352,000
Q3 2020

Nov 12, 2020

BUY
$8.02 - $11.73 $34,750 - $50,826
4,333 Added 4.84%
93,928 $785,000
Q2 2020

Jul 31, 2020

BUY
$5.37 - $9.45 $80,383 - $141,457
14,969 Added 20.06%
89,595 $695,000
Q1 2020

May 01, 2020

BUY
$4.56 - $7.13 $36,958 - $57,788
8,105 Added 12.18%
74,626 $435,000
Q4 2019

Feb 14, 2020

BUY
$4.97 - $7.7 $320,405 - $496,403
64,468 Added 3140.19%
66,521 $454,000
Q3 2019

Nov 14, 2019

BUY
$5.11 - $5.99 $10,490 - $12,297
2,053 New
2,053 $11,000
Q1 2019

May 14, 2019

SELL
$5.12 - $6.18 $17,387 - $20,987
-3,396 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$4.68 - $6.25 $987 - $1,318
211 Added 6.62%
3,396 $17,000
Q3 2018

Nov 14, 2018

BUY
$5.15 - $6.3 $1,972 - $2,412
383 Added 13.67%
3,185 $20,000
Q2 2018

Aug 14, 2018

SELL
$4.4 - $5.3 $787 - $948
-179 Reduced 6.0%
2,802 $15,000
Q1 2018

May 15, 2018

BUY
$4.6 - $5.75 $12,332 - $15,415
2,681 Added 893.67%
2,981 $14,000
Q4 2017

Feb 14, 2018

BUY
$4.35 - $5.15 $1,305 - $1,545
300 New
300 $1,000
Q3 2017

Nov 14, 2017

SELL
$4.25 - $4.8 $2,805 - $3,168
-660 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
561 Added 566.67%
660 $4,000
Q1 2017

Nov 14, 2017

BUY
N/A
99
99 $1,000

Others Institutions Holding KMDA

About KAMADA LTD


  • Ticker KMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 44,800,500
  • Market Cap $246M
  • Description
  • Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...
More about KMDA
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.